Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply

PT Lakkakorpi; HK Vaananen; Pirkko Härkönen

Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply

PT Lakkakorpi, HK Vaananen, Pirkko Härkönen

Department of Translational Medicine

Research output: Contribution to journal › Letter

Original language	English
Pages (from-to)	2935-2936
Journal	Cancer Research
Volume	64
Issue number	8
Publication status	Published - 2004

Bibliographical note

Department affilation moved from v1000588 (Tumour Biology, Malmö) to v1000562 (Department of Translational Medicine) on 2016-01-18 14:39:31.

Subject classification (UKÄ)

Cancer and Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://cancerres.aacrjournals.org/cgi/content/full/64/8/2934

Cite this

Lakkakorpi, PT., Vaananen, HK., & Härkönen, P. (2004). Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply. Cancer Research, 64(8), 2935-2936. http://cancerres.aacrjournals.org/cgi/content/full/64/8/2934

Lakkakorpi, PT ; Vaananen, HK ; Härkönen, Pirkko. / Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply. In: Cancer Research. 2004 ; Vol. 64, No. 8. pp. 2935-2936.

@article{726b8ea6402240d989b1e2f754acf645,

title = "Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply",

author = "PT Lakkakorpi and HK Vaananen and Pirkko H{\"a}rk{\"o}nen",

note = "Department affilation moved from v1000588 (Tumour Biology, Malm{\"o}) to v1000562 (Department of Translational Medicine) on 2016-01-18 14:39:31.",

year = "2004",

language = "English",

volume = "64",

pages = "2935--2936",

journal = "Cancer Research",

issn = "1538-7445",

publisher = "American Association for Cancer Research Inc.",

number = "8",

}

Lakkakorpi, PT, Vaananen, HK & Härkönen, P 2004, 'Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply', Cancer Research, vol. 64, no. 8, pp. 2935-2936. <http://cancerres.aacrjournals.org/cgi/content/full/64/8/2934>

Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply. / Lakkakorpi, PT; Vaananen, HK; Härkönen, Pirkko.
In: Cancer Research, Vol. 64, No. 8, 2004, p. 2935-2936.

Research output: Contribution to journal › Letter

TY - JOUR

T1 - Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply

AU - Lakkakorpi, PT

AU - Vaananen, HK

AU - Härkönen, Pirkko

N1 - Department affilation moved from v1000588 (Tumour Biology, Malmö) to v1000562 (Department of Translational Medicine) on 2016-01-18 14:39:31.

PY - 2004

Y1 - 2004

M3 - Letter

SN - 1538-7445

VL - 64

SP - 2935

EP - 2936

JO - Cancer Research

JF - Cancer Research

IS - 8

ER -

Lakkakorpi PT, Vaananen HK, Härkönen P. Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply. Cancer Research. 2004;64(8):2935-2936.